/* Accessibility: focus indicators */ a:focus-visible, button:focus-visible, [tabindex]:focus-visible, select:focus-visible, summary:focus-visible { outline: 2px solid #4F46E5 !important; outline-offset: 2px !important; border-radius: 6px; } input:focus-visible, textarea:focus-visible { outline: none !important; border-color: #4F46E5 !important; box-shadow: 0 0 0 3px rgba(79, 70, 229, 0.2) !important; } Skip to main content
JournalistDB
Get Started
RL

Ron Leuty

Biotech Reporter, San Francisco Business Times

San Francisco Business Times

r***@bizjournals.com Upgrade
Pro only
Albany, New York, United States
www.bizjournals.com

About

#Biotech reporter @SFBusinessTimes; hardcore @Tigers fan; once rolled a 288. Tip me: rleuty@bizjourn...

Upgrade to read full bio

Beats & Topics

Business Metro San Francisco Finance Health Opinion Editorial Culture Agriculture Events Biotechnology Biography Sketch Spas Style Entertainment Biotech

Industries

Publishing

Published In

Cnbc The Atlantic Yahoo Finance Buffalo Business First Denver Business Journal Linkedin Boston Business Journal Bizwomen Columbus Business First Albany Business Review San Francisco Business Times

Recent Article

With BioMarin deal, Spruce Biosciences hits reset on rare-disease drug - San Francisco Business Times

Upgrade for article links
4,121 total articles published